TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 15,737 | 5,135 | 2,739 |
Financial expenses | 0 | 9 | 0 |
Earnings before taxes | 1,556 | -5,033 | -5,401 |
EBITDA | 1,594 | -5,001 | -5,390 |
Total assets | 68,015 | 73,921 | 43,196 |
Current assets | 24,055 | 32,589 | 7,959 |
Current liabilities | 4,807 | 6,855 | 4,632 |
Equity capital | 63,208 | 67,066 | 38,564 |
- share capital | 1,795 | 1,953 | 1,545 |
Employees (average) | 10 | 9 | 8 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 92.9% | 90.7% | 89.3% |
Turnover per employee | 1,574 | 571 | 342 |
Profit as a percentage of turnover | 9.9% | -98.0% | -197.2% |
Return on assets (ROA) | 2.3% | -6.8% | -12.5% |
Current ratio | 500.4% | 475.4% | 171.8% |
Return on equity (ROE) | 2.5% | -7.5% | -14.0% |
Change turnover | 11,018 | 2,448 | 1,951 |
Change turnover % | 233% | 247% | |
Chg. No. of employees | 1 | 1 | -1 |
Chg. No. of employees % | 11% | -11% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.